References

Thyroid cancer: a review

10.1001/jama.2023.26348 · 2024 · External reference

Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy

10.1016/j.drup.2023.100939 · 2023 · External reference

Cancer incidence and mortality across diverse geographical regions in China, 2024

10.3760/cma.j.cn112152-20260205-00079 · 2026 · External reference

Prognostic value of preablative stimulated thyroglobulin and its decline after 131I therapy in differentiated thyroid cancer

10.1080/07853890.2025.2573150 · 2025 · External reference

Current controversies in low-risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis

10.1210/clinem/dgac646 · 2023 · External reference

Development and validation of a machine learning model for dementia staging in a heterogeneous cognitive impairment cohort using multimodal features

10.1016/j.acra.2026.01.009 · 2026 · External reference

2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer

10.1177/10507256251363120 · 2025 · External reference

Unresolved reference

External reference

2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer

10.1089/thy.2015.0020 · 2016 · External reference

Guidelines for radioiodine therapy of differentiated thyroid cancer (2021 edition)

10.3760/cma.j.cn321828-20201113-00412 · 2021 · External reference

Regression shrinkage and selection via the lasso

10.1111/j.2517-6161.1996.tb02080.x · 1996 · External reference

Feature selection with the Boruta package

10.18637/jss.v036.i11 · 2010 · External reference

Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

10.1038/s41467-024-46043-y · 2024 · External reference

Scikit-learn: machine learning in Python

2011 · External reference

Scikit-survival: a library for time-to-event analysis built on top of scikit-learn

2020 · External reference

Unresolved reference

External reference

The outcome of I-131 ablation therapy for intermediate and high-risk differentiated thyroid cancer using a strict definition of successful ablation

10.1007/s11604-017-0660-9 · 2017 · External reference

Stimulated thyroglobulin and thyroglobulin reduction index predict excellent response in differentiated thyroid cancers

10.1210/jc.2018-02680 · 2019 · External reference

Efficacy assessment of repeat iodine-131 treatment in patients with papillary thyroid carcinoma assessed as biochemical incomplete response

10.1007/s12020-025-04232-9 · 2025 · External reference

Adequate dose of levothyroxine for thyroid-stimulating hormone suppression after total thyroidectomy in patients with differentiated thyroid cancer

10.3803/enm.2023.1896 · 2024 · External reference

Clinical role of pre-ablation stimulated thyroglobulin and thyroid-stimulating hormone ratio for radioactive iodine treatment in adults with papillary thyroid cancer

10.1016/j.clon.2025.103797 · 2025 · External reference

A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: a bi-center retrospective study

10.1007/s12020-023-03625-y · 2024 · External reference

Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect

10.3389/fendo.2023.1307325 · 2024 · External reference

Comparison of antithyroglobulin antibody concentrations before and after ablation with 131I as a predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography

10.1089/thy.2015.0445 · 2016 · External reference

Hashimoto’s thyroiditis: a “double-edged sword” in thyroid carcinoma

10.3389/fendo.2022.801925 · 2022 · External reference

The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer

10.3389/fendo.2022.1026737 · 2022 · External reference

Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition)

10.1007/s00259-025-07222-1 · 2025 · External reference

Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study

10.1038/s41598-025-18385-0 · 2025 · External reference